OPPENHEIMER ASSET MANAGEMENT INC.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1269119
NEW YORK, NY
Position in ALNY
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$6,565,122
+$364,964 QoQ
Shares Held
19,842
+27.3% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026OPPENHEIMER ASSET MANAGEMENT INC. holds $55,806,770 across 25 Biotechnology names. ALNY ranks #4 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
457,508 | $12,274,939 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
32,532 | $9,661,028 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,302 | $7,726,032 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
19,842 | $6,565,122 | |
| 5 | TECH |
BIO-TECHNE Corp
|
47,921 | $2,504,348 | |
| 6 | INSM |
INSMED Inc
|
14,725 | $2,407,831 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
29,569 | $1,911,043 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,405 | $1,858,198 |
All Filings in ALNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,565,122 | 19,842 | Shares | Other | 2026-04-24 | |
| 2025-12-31 | $6,200,158 | 15,592 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $1,960,800 | 4,300 | Shares | Other | 2025-11-06 | |
| 2025-06-30 | $433,047 | 1,328 | Shares | Other | 2025-07-31 | |
| 2020-03-31 | $28,409 | 261 | Shares | Other | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||